Karyopharm Therapeutics | 销售和管理费用

Selling And Administration Expenses 更改 日
Amgen USD 1.76B 424M 2023-12
AstraZeneca USD 3.91B 194M 2023-09
Avrobio USD 6.26M 1.68M 2023-09
Eli Lilly USD 1.92B 120.7M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Incyte USD 293.86M 25.97M 2023-12
Pfizer USD 4.47B 1.27B 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Takeda JPY 252.95B 4.84B 2023-09
TG Therapeutics USD 31.15M 1.62M 2023-12
Ultragenyx Pharmaceutical USD 76.83M 1.92M 2023-12
Xencor USD 15.48M 2.98M 2023-12



Karyopharm Therapeutics 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2024.